We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+16.3%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$36.7B
AUM Growth
+$4.73B
Cap. Flow
+$3.45B
Cap. Flow %
9.42%
Top 10 Hldgs %
15.54%
Holding
3,403
New
385
Increased
1,787
Reduced
944
Closed
189

Sector Composition

Rank Sector Weight
1 Healthcare 9.66%
2 Technology 9.09%
3 Financials 7.96%
4 Consumer Staples 7.25%
5 Industrials 7.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPK icon
3151
PUT
Opko Health
OPK
$1.02B
$10K ﹤0.01%
65,000
CMLS
3152
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$10K ﹤0.01%
3,902
ABBV icon
3153
CALL
AbbVie
ABBV
$435B
$9K ﹤0.01%
21,500
+1,400
+7% +$90.6K
BMY icon
3154
CALL
Bristol-Myers Squibb
BMY
$132B
$9K ﹤0.01%
53,300
-11,100
-17% -$713K
CMCSA icon
3155
CALL
Comcast
CMCSA
$90B
$9K ﹤0.01%
44,000
+400
+0.9% +$13.3K
DNN icon
3156
Denison Mines
DNN
$2.91B
$9K ﹤0.01%
19,457
+3,000
+18% +$1.55K
CDMO
3157
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$9K ﹤0.01%
2,937
-428
-13% -$1.15K
AMPE
3158
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$9K ﹤0.01%
+41
New +$11.5K
GSS
3159
DELISTED
Golden Star Resources Ltd.
GSS
$9K ﹤0.01%
2,200
-920
-29% -$3.6K
EPD icon
3160
CALL
Enterprise Products Partners
EPD
$81.7B
$8K ﹤0.01%
31,000
+3,500
+13% +$96.7K
PTN
3161
Palatin Technologies
PTN
$13.8M
$8K ﹤0.01%
+10
New +$7.02K
TT icon
3162
CALL
Trane Technologies
TT
$106B
$8K ﹤0.01%
16,800
+3,200
+24% +$213K
IRDM icon
3163
CALL
Iridium Communications
IRDM
$5.29B
$7K ﹤0.01%
+46,600
New +$391K
USO icon
3164
CALL
United States Oil Fund
USO
$1.67B
$7K ﹤0.01%
2,550
-775
-23% -$65.1K
CRM icon
3165
CALL
Salesforce
CRM
$158B
$6K ﹤0.01%
+13,900
New +$1.08M
GSK icon
3166
CALL
GSK
GSK
$106B
$6K ﹤0.01%
51,280
+7,200
+16% +$395K
MAR icon
3167
CALL
Marriott International
MAR
$92.3B
$6K ﹤0.01%
15,100
-10,300
-41% -$726K
PII icon
3168
CALL
Polaris
PII
$4.07B
$6K ﹤0.01%
+10,400
New +$903K
XOMA
3169
DELISTED
Xoma
XOMA
$6K ﹤0.01%
651
CAH icon
3170
CALL
Cardinal Health
CAH
$55.4B
$5K ﹤0.01%
50,100
+1,700
+4% +$137K
ORCL icon
3171
CALL
Oracle
ORCL
$423B
$5K ﹤0.01%
193,500
+99,500
+106% +$4.05M
CTSH icon
3172
CALL
Cognizant
CTSH
$26B
$4K ﹤0.01%
+16,600
New +$944K
GILD icon
3173
CALL
Gilead Sciences
GILD
$165B
$4K ﹤0.01%
+11,200
New +$910K
HSBC icon
3174
CALL
HSBC
HSBC
$356B
$4K ﹤0.01%
14,280
-3,341
-19% -$105K
PVCT
3175
DELISTED
PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
$4K ﹤0.01%
42,620

Similar funds

Raymond James & Associates's Q3 2016 Portfolio in Review

As of Q3 2016, Raymond James & Associates held 3,403 positions worth $36.7B, up 15% from $31.9B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Raymond James & Associates deployed $3.45B of net new capital in Q3 2016, opening 385 new positions and adding to 1,787 existing holdings. Its largest new stake was iShares MSCI India Small-Cap ETF: 414,364 shares worth $15.2M.

By sector, the portfolio is most concentrated in Healthcare at 9.7% of assets, up from 9.6% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was TotalEnergies, an estimated $614M trimmed.

  • Raymond James & Associates's largest Q3 2016 buy was iShares MSCI India Small-Cap ETF: 414,364 shares worth $15.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2016, an estimated $196M increase.
  • Raymond James & Associates's biggest Q3 2016 reduction was TotalEnergies, cutting an estimated $614M.
  • Raymond James & Associates fully exited TYCO INTL PLC COM SHS (IRL) in Q3 2016, selling an estimated $61.1M.
  • Raymond James & Associates's ten largest holdings make up 16% of its $36.7B portfolio in Q3 2016.
  • Raymond James & Associates opened 385 new positions and closed 189 in Q3 2016.
  • Raymond James & Associates's portfolio value rose 15% quarter-over-quarter to $36.7B.

Based on Raymond James & Associates's 13F filing for Q3 2016, filed 14 Nov 2016.